1	Iniciar	iniciar	VMN0000	-	-	0-7	93(1)_ANS_clinical_caseMIR	SENT1	-	-
2	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	8-19	93(1)_ANS_clinical_caseMIR	SENT1	-	-
3	con	con	SPS00	C0332287	atributo	20-23	93(1)_ANS_clinical_caseMIR	SENT1	-	-
4	prednisona	prednisona	NCFS000	C0032952	sustancia	24-34	93(1)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
5	60	60	Z	-	-	35-37	93(1)_ANS_clinical_caseMIR	SENT1	-	-
6	mg	mg	NCMN000	-	-	38-40	93(1)_ANS_clinical_caseMIR	SENT1	-	-
7	al	al	SP+DA	-	-	41-43	93(1)_ANS_clinical_caseMIR	SENT1	-	-
8	día	día	NCMS000	C0439228#C0332169	calificador	44-47	93(1)_ANS_clinical_caseMIR	SENT1	-	-
9	y	y	CC	C1706368	calificador	48-49	93(1)_ANS_clinical_caseMIR	SENT1	-	-
10	aspirina	aspirina	NCFS000	C0004057	sustancia	50-58	93(1)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
11	100	100	Z	-	-	59-62	93(1)_ANS_clinical_caseMIR	SENT1	-	-
12	mg	mg	NCMN000	-	-	63-65	93(1)_ANS_clinical_caseMIR	SENT1	-	-
13	al	al	SP+DA	-	-	66-68	93(1)_ANS_clinical_caseMIR	SENT1	-	-
14	día	día	NCMS000	C0439228#C0332169	calificador	69-72	93(1)_ANS_clinical_caseMIR	SENT1	-	-
15	.	.	Fp	-	-	72-73	93(1)_ANS_clinical_caseMIR	SENT1	-	-

